Valuation: Emblem Corp

Market Cap 248M 222M 205M 186M 347M 23.57B 353M 2.47B 976M 12.35B 932M 912M 38.94B P/E 2017
-16.3x
P/E 2018 -4.48x
Enterprise Value 219M 196M 181M 164M 307M 20.82B 312M 2.18B 862M 10.91B 823M 805M 34.38B EV / Sales 2017
72,352,077x
EV / Sales 2018 10,915,686x
Free-Float
98.36%
Yield 2017 *
-
Yield 2018 -
Manager TitleAgeSince
Chief Executive Officer - -
Chief Executive Officer - 2017-11-30
Investor Relations Contact - -
Director TitleAgeSince
Director/Board Member - -
Director/Board Member - -
Director/Board Member - 2016-12-05
Change 5-day change 1-year change 3-year change Capi.($)
+1.62%+1.62% - - 0
-2.06%+1.87%+55.96%+122.05% 1,165B
-1.73%+2.91%+36.64%+73.72% 645B
-0.00%-0.15%+24.85%+96.90% 504B
-0.31%+3.09%+43.92%+64.55% 380B
-1.87%-0.76%+66.14%+40.15% 363B
-0.68%+2.65%+22.46%+51.48% 297B
-1.20%+3.04%+2.62%+26.97% 269B
-1.18%+2.27%+51.02%+61.98% 237B
-0.17%+0.43%+29.92%+102.24% 195B
Average -0.78%+2.45%+37.06%+71.12% 405.55B
Weighted average by Cap. -1.29%+3.17%+41.27%+82.57%

Financials

2017 2018
Net sales 2.69 2.41 2.22 2.01 3.77 255.74 3.83 26.74 10.59 133.99 10.11 9.9 422.44 8.22 7.34 6.78 6.15 11.5 780.6 11.69 81.63 32.32 408.98 30.86 30.2 1.29K
Net income -12.1M -10.81M -9.98M -9.05M -16.93M -1.15B -17.21M -120M -47.56M -602M -45.41M -44.45M -1.9B -24.26M -21.66M -20.01M -18.14M -33.93M -2.3B -34.49M -241M -95.35M -1.21B -91.04M -89.11M -3.8B
Net Debt -21.51M -19.21M -17.75M -16.08M -30.09M -2.04B -30.59M -214M -84.55M -1.07B -80.73M -79.02M -3.37B -29.05M -25.94M -23.97M -21.72M -40.64M -2.76B -41.31M -288M -114M -1.45B -109M -107M -4.56B
Logo Emblem Corp
Emblem Corp is a Canada-based Company engaged in alternative medicine sector. The Company is producer and distributor of medical cannabis and cannabis derivatives licensed under the Access to Cannabis for Medical Purposes Regulations (ACMPR). The Company operates in one segment, the production and sale of medical cannabis to patients who have received medical authorizations to acquire and use cannabis. The Company offers fully integrated services covering the full cannabis spectrum, from growing to selling, as well as educating and also creating new forms of cannabinoid-based medication in standardized dosages. All of the Company’s assets are located in Canada.
Employees
-